Literature DB >> 10084346

Six-month outcome following a relapse of schizophrenia.

J Bergen1, G Hunt, P Armitage, M Bashir.   

Abstract

OBJECTIVE: To analyse clinical data on patients with schizophrenia on admission to acute care and 6 months later in order to identify factors associated with frequent hospitalisations and poor outcome.
METHOD: Information was collected from the medical records of 99 patients with schizophrenia consecutively admitted to acute care in hospital or by community based 24 h Crisis Teams and prospectively studied for 6 months.
RESULTS: One-quarter of patients were being admitted to acute care within 3 months of their last hospital discharge and only 34 patients were compliant with their neuroleptic medication 3 months prior to the index admission. Twenty-one patients were managed entirely by the Crisis Teams, 27 patients received inpatient care only and the remainder (n = 51) had both types of acute care. Six months after admission, 42 patients had been discharged and did not require further acute care, 29 patients had been re-admitted at least once and three patients had been transferred to an inpatient rehabilitation unit and, therefore, remained in hospital over the entire period. Of the remaining 25 patients, one committed suicide 2 months after discharge and the other patients were not contactable by Community Mental Health Teams at the 2 and/or 6 month follow up.
CONCLUSIONS: Some of the factors associated with relapse identified in the present study were non-compliance with medication, stress, inadequate social support and substance abuse. The poor outcome in patients with frequent relapses emphasises the need to reduce the occurrences of schizophrenic symptoms to provide a better quality of life. The 25% of patients dropping out of care soon after a relapse indicates that more should be done to engage these people in long-term treatment programs.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10084346     DOI: 10.3109/00048679809073871

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  16 in total

1.  Effectiveness of a low-intensity home-based aftercare for patients with severe mental disorders: a 12-month randomized controlled study.

Authors:  Vandad Sharifi; Mehdi Tehranidoost; Masud Yunesian; Homayoun Amini; Mohammadreza Mohammadi; Mohsen Jalali Roudsari
Journal:  Community Ment Health J       Date:  2012-07-07

2.  Time-lagged predictors of daily medication nonadherence beliefs during the month post-hospital discharge in patients with psychotic-spectrum disorders.

Authors:  Brandon A Gaudiano; Stacy Ellenberg; Lawrence H Price; Ethan Moitra
Journal:  Psychiatry Res       Date:  2018-09-21       Impact factor: 3.222

3.  Multiple informants in assessing stress and symptoms in adolescents with schizophrenia.

Authors:  Heeyoung Lee; Karen G Schepp
Journal:  Arch Psychiatr Nurs       Date:  2010-08-16       Impact factor: 2.218

Review 4.  Suicide Rates After Discharge From Psychiatric Facilities: A Systematic Review and Meta-analysis.

Authors:  Daniel Thomas Chung; Christopher James Ryan; Dusan Hadzi-Pavlovic; Swaran Preet Singh; Clive Stanton; Matthew Michael Large
Journal:  JAMA Psychiatry       Date:  2017-07-01       Impact factor: 21.596

5.  Influences of attribution and stigma on working relationships with providers practicing Western psychiatry in the Taiwanese context.

Authors:  Fang-Pei Chen; Hui-Ching Wu; Chun-Jen Huang
Journal:  Psychiatr Q       Date:  2014-12

6.  Medication adherence for children and adolescents with first-episode psychosis following hospitalization.

Authors:  Robin E Gearing; Alice Charach
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-04-21       Impact factor: 4.785

7.  An approach to maximizing treatment adherence of children and adolescents with psychotic disorders and major mood disorders.

Authors:  Robin Edward Gearing; Irfan A Mian
Journal:  Can Child Adolesc Psychiatr Rev       Date:  2005-11

8.  Outpatient antipsychotic treatment and inpatient costs of schizophrenia.

Authors:  Steven C Marcus; Mark Olfson
Journal:  Schizophr Bull       Date:  2007-06-19       Impact factor: 9.306

9.  Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program.

Authors:  Susan M Abughosh; Stephen J Kogut
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

10.  Treatment of schizophrenia with long-acting fluphenazine, haloperidol, or risperidone.

Authors:  Mark Olfson; Steven C Marcus; Haya Ascher-Svanum
Journal:  Schizophr Bull       Date:  2007-04-29       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.